The company aims to develop technical devices and laboratory systems for the exploration of the human gastrointestinal tract in disease and health, and to trade in such devices. The company may establish branches and subsidiaries in Switzerland and abroad, participate in other companies in Switzerland and abroad, take over representations and conduct all business and conclude contracts that may be suitable to promote the purpose of the company or that are directly or indirectly related to it. It may acquire, hold, encumber and sell real estate in Switzerland and abroad. The company may grant or receive direct or indirect financing to its direct or indirect subsidiaries and third parties, including its direct or indirect shareholders and their direct or indirect subsidiaries, and provide or receive security of any kind for the liabilities of such companies, including by way of pledges on or fiduciary transfers of the company's assets or guarantees of any kind, whether paid or unpaid.